DRD3

DRD3 is a G protein-coupled dopamine receptor that couples dopaminergic signaling to intracellular trafficking, autophagy, and circuit-level control of social and reward-related behavior. Palmitoylation of DRD3 remodels its cytoplasmic domain to recruit the adaptor GIPC1, functioning as a molecular switch for biased signaling and receptor trafficking (PMID:26787837). DRD3 activates an AMPK→MTORC1 inhibition→ULK1 autophagy axis distinct from DRD2, while preserving protein synthesis via MAPK1/3-RPS6KA signaling; in astrocytes this DRD3-dependent autophagy suppresses NLRP3 inflammasome activation (PMID:31538542, PMID:35896696). In the brain, DRD3 is a direct transcriptional target of the circadian factor NPAS2 in nucleus accumbens, mediates early-life-stress-induced social dysfunction in lateral septum neurons, and drives cocaine-seeking relapse through a ventral pallidum→lateral habenula circuit (PMID:25444159, PMID:29276054, PMID:34048697).

1. 2004 Medium

   Establishing that DRD3 is required for conditioned drug reward answered whether this receptor subtype has a non-redundant role in associative reward learning beyond DRD2.

   Evidence DRD3-knockout mice and DRD3-selective partial agonist BP897 tested in morphine conditioned place preference with c-fos mapping

   PMID:15371743

   Open questions at the time

   • Downstream signaling pathways mediating conditioned reward were not identified
   • Results from a single lab without independent replication
   • No comparison with DRD2-specific manipulations in the same paradigm
2. 2014 High

   Demonstrating that the circadian protein NPAS2 directly binds and transcriptionally regulates Drd3 in nucleus accumbens established that DRD3 expression is under circadian transcriptional control, linking clock mechanisms to dopamine receptor availability and cocaine reward.

   Evidence ChIP-seq for NPAS2 binding at Drd3 locus, AAV-shRNA knockdown of NPAS2 in NAc, cell-sorting qRT-PCR, conditioned place preference in mice

   PMID:25444159

   Open questions at the time

   • Whether other clock genes redundantly regulate Drd3 is unknown
   • Post-transcriptional regulation of DRD3 protein rhythms not assessed
   • Causal role of Drd3 rhythm itself in cocaine reward not isolated from other NPAS2 targets
3. 2016 High

   Showing that palmitoylation remodels the DRD3 C-terminal domain to expose a GIPC1 docking site resolved how a single post-translational modification can switch DRD3 between signaling and trafficking modes.

   Evidence Molecular dynamics simulation, co-immunoprecipitation, live-cell imaging, and palmitoylation-site mutagenesis

   PMID:26787837

   Open questions at the time

   • Identity of the palmitoyl acyltransferase(s) modifying DRD3 is unknown
   • Functional consequences of GIPC1-dependent trafficking in neurons in vivo not tested
   • Whether palmitoylation-dependent bias extends to G-protein versus β-arrestin signaling not resolved
4. 2017 High

   Demonstrating that DRD3 signaling in lateral septum neurons is both necessary and sufficient for normal social behavior—and that early life stress blunts this pathway—established a specific circuit-level function for DRD3 beyond reward.

   Evidence In vivo Ca2+ imaging, optogenetic activation and inhibition of Drd3-expressing LS neurons, pharmacological DRD3 agonist rescue in early-life-stress mouse model

   PMID:29276054

   Open questions at the time

   • Intracellular signaling cascade downstream of DRD3 in LS neurons not delineated
   • Epigenetic mechanism by which ELS downregulates Drd3 not identified
   • Whether DRD3 LS function generalizes across species unknown
5. 2019 High

   Identifying that DRD3 activates autophagy through AMPK→RPTOR→MTORC1 inhibition→ULK1 while maintaining protein synthesis via MAPK1/3-RPS6KA distinguished a DRD3-specific signaling branch from DRD2 and linked dopamine receptor activation to autophagy regulation.

   Evidence DRD3-overexpressing cells, Drd3-knockout mice, pramipexole treatment, Western blotting for AMPK/MTOR/ULK1/MAPK pathway components, LC3 autophagy assays

   PMID:31538542

   Open questions at the time

   • Physiological stimuli that engage this pathway in vivo not defined
   • Whether the AMPK-MTORC1 axis operates in neurons versus glia not resolved
   • Structural basis for DRD3-selective AMPK activation unknown
6. 2021 High

   Mapping DRD3-dependent plasticity in ventral pallidum neurons projecting to lateral habenula as a driver of cocaine-seeking relapse identified the circuit through which DRD3 controls drug relapse after abstinence.

   Evidence Circuit-specific optogenetics, DRD3 signaling manipulation, dopamine release imaging in VP→LHb and VP→VTA projections during cocaine self-administration and relapse

   PMID:34048697

   Open questions at the time

   • Molecular nature of the DRD3-dependent plasticity in VP neurons not characterized
   • Whether VP DRD3 function generalizes to other drugs of abuse not tested
   • Contribution of DRD3 heteromerization in VP not addressed
7. 2022 High

   Extending the DRD3-autophagy link to astrocytes and demonstrating that DRD3-driven autophagy suppresses NLRP3 inflammasome activation provided a neuroimmune mechanism for DRD3 agonist neuroprotection.

   Evidence Drd3 siRNA and Atg5 knockdown in primary astrocytes and LPS-induced PD mouse model, NLRP3 inflammasome and autophagy marker assays

   PMID:35896696

   Open questions at the time

   • Whether endogenous dopamine engages this axis at physiological concentrations unknown
   • Selectivity of the effect for astrocytes versus microglia or neurons not fully dissected
   • Long-term in vivo neuroprotective efficacy not established

• The structural basis for DRD3-selective activation of AMPK, the identity of palmitoyl transferases that modify DRD3, and how DRD3 heteromerization influences circuit-level functions remain open questions.
• No high-resolution structure of DRD3 in complex with GIPC1 or downstream effectors
• Epigenetic mechanisms by which early life stress downregulates Drd3 in lateral septum not identified
• Role of DRD3 heteromers (e.g., DRD1-DRD3) in any of the described circuits not tested